The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(1-(4-(1-methyl-1H-pyrazol-4-yl)benzyl)-1H-1,2,3-triazol-4-yl)phenyl)cyclopropanecarboxamide ID: ALA4539395
PubChem CID: 150533442
Max Phase: Preclinical
Molecular Formula: C23H22N6O
Molecular Weight: 398.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2ccc(Cn3cc(-c4cccc(NC(=O)C5CC5)c4)nn3)cc2)cn1
Standard InChI: InChI=1S/C23H22N6O/c1-28-14-20(12-24-28)17-7-5-16(6-8-17)13-29-15-22(26-27-29)19-3-2-4-21(11-19)25-23(30)18-9-10-18/h2-8,11-12,14-15,18H,9-10,13H2,1H3,(H,25,30)
Standard InChI Key: IEIGLLZCPLOVEA-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
38.8260 -22.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5326 -23.3087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2382 -22.8982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2356 -22.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5214 -21.6744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8186 -22.0873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9412 -21.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6515 -22.0694 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.6552 -22.8901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4368 -23.1402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.9163 -22.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4308 -21.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7335 -22.4703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1414 -23.1777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9578 -23.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3640 -22.4642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9478 -21.7561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1328 -21.7629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1207 -24.1332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1199 -23.3111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3377 -23.0578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8551 -23.7234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3391 -24.3880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.0379 -23.7243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3507 -21.0451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.1679 -21.0385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.5707 -20.3275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.5822 -21.7429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
47.2716 -19.9141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.5606 -19.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 8 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 1 0
23 19 2 0
22 24 1 0
17 25 1 0
25 26 1 0
26 27 1 0
26 28 2 0
29 27 1 0
30 29 1 0
27 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.47Molecular Weight (Monoisotopic): 398.1855AlogP: 3.74#Rotatable Bonds: 6Polar Surface Area: 77.63Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.77CX Basic pKa: 1.83CX LogP: 3.87CX LogD: 3.87Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.54Np Likeness Score: -2.33
References 1. Shan Y, Si R, Wang J, Zhang Q, Zhou H, Song J, Zhang J, Chen Q.. (2019) Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs., 164 [PMID:30616052 ] [10.1016/j.ejmech.2018.12.067 ]